drugset / Trial / NCT01119352

AZD7687 Multiple Ascending Dose Study

NCT01119352 ↗

Phase 1 Completed 45 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindBasic science

Summary

The aim of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD7687 following multiple ascending dose administrations in in overweight to obese but otherwise healthy male subjects

Timeline

Start
2010-04
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7687 Small molecule 1 mg Oral

Indications